Physician profile
Melanie Smith
NPI 1023092343
$1,166.89
in general payments reported to CMS, 2019-2025
19 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.21 · 2020: $68.29 · 2021: $67.85 · 2022: $161 · 2023: $133 · 2024: $161 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $231.74 | 2022-2025 | Clareon, Tryptyr, Rocklatan |
| Bausch & Lomb Americas INC. | $204.26 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $139.08 | 2022-2025 | |
| Rxsight INC | $97.99 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Amgen INC. | $66.95 | 2024-2025 | Tepezza |
| Shire North American Group INC | $58.21 | 2019 | |
| Abbvie INC. | $48.95 | 2022-2025 | Lumigan, Vuity |
| Allergan, INC. | $43.75 | 2020-2021 | |
| Oyster Point Pharma, INC. | $36.63 | 2022 | |
| Abbott Laboratories | $34.78 | 2023 | Navitor |
| Sun Pharmaceutical Industries INC. | $33.05 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.25 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $23.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.40 | 2024 | Ultomiris |
| Kala Pharmaceuticals, INC. | $21.86 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.85 | 2020 | |
| Aerie Pharmaceuticals, INC. | $17.43 | 2021 | |
| Harrow Eye, LLC | $17.32 | 2024 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $16.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.